Yuhan (YUHNF) Cyclically Adjusted Book per Share: $0.00 (As of Mar. 2026)


What is Yuhan Cyclically Adjusted Book per Share?

Yuhan YUHNF 79 Cyclically Adjusted Book per Share is $0.00 as of Mar. 2026. GuruFocus rates YUHNF with a GF Score™ of 79/100. The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Yuhan's adjusted book value per share for the three months ended in Mar. 2026 was $20.526. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Yuhan's average Cyclically Adjusted Book Growth Rate was 5.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Yuhan was 7.80% per year. The lowest was 5.60% per year. And the median was 6.80% per year.

As of today (2026-07-06), Yuhan's current stock price is $0.00. Yuhan's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.00. Yuhan's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Yuhan was 6.30. The lowest was 1.52. And the median was 2.41.


Yuhan  (OTCPK:YUHNF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Yuhan was 6.30. The lowest was 1.52. And the median was 2.41.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Yuhan Cyclically Adjusted Book per Share Related Terms


Yuhan Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Yuhan's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yuhan Cyclically Adjusted Book per Share Chart

Yuhan Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Yuhan Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

YUHNF vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuhan Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Yuhan's Cyclically Adjusted PB Ratio falls into.



Yuhan Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yuhan's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=20.526/125.2360*125.2360
=20.526

Current CPI (Mar. 2026) = 125.2360.

Yuhan Quarterly Data

Book Value per Share CPI Adj_Book
201606 16.327 100.791 20.287
201609 17.456 101.461 21.546
201612 17.612 101.561 21.717
201703 17.579 102.851 21.405
201706 17.952 102.611 21.910
201709 18.225 103.491 22.054
201712 20.382 102.991 24.784
201803 19.670 104.101 23.664
201806 19.471 104.130 23.417
201809 19.120 105.651 22.664
201812 20.258 104.351 24.313
201903 19.070 104.491 22.856
201906 18.346 104.881 21.907
201909 18.131 105.200 21.584
201912 19.455 105.121 23.178
202003 18.800 105.354 22.348
202006 19.625 105.112 23.382
202009 20.827 106.198 24.561
202012 23.362 105.765 27.663
202103 21.714 107.357 25.330
202106 22.186 107.579 25.827
202109 21.489 108.759 24.745
202112 22.676 109.676 25.893
202203 20.653 111.848 23.125
202206 19.964 114.072 21.918
202209 18.291 114.715 19.968
202212 21.460 115.179 23.334
202303 20.127 116.507 21.635
202306 20.143 117.182 21.527
202309 19.789 118.964 20.832
202312 22.010 118.837 23.195
202403 20.297 120.123 21.161
202406 19.832 120.007 20.696
202409 21.228 120.861 21.996
202412 19.454 121.135 20.113
202503 18.917 122.590 19.325
202506 21.018 122.611 21.468
202509 20.700 123.402 21.008
202512 21.046 123.939 21.266
202603 20.526 125.236 20.526

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
Yuhan (YUHNF) has a Cyclically Adjusted Book per Share of $0.00 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Yuhan and its competitors.
Is Yuhan's Cyclically Adjusted Book per Share too high?
Yuhan's current Cyclically Adjusted Book per Share is $0.00. Overall, Yuhan has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Yuhan's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Yuhan's Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Yuhan and its competitors. Yuhan's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yuhan stock overvalued right now?
Yuhan (YUHNF) has a current Cyclically Adjusted Book per Share of $0.00. The current Cyclically Adjusted Book per Share is $0.00. Yuhan's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Yuhan (YUHNF), the current Cyclically Adjusted Book per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yuhan Business Description

Other Exchanges 000105:Korea000100:Korea
Address 74 Noryangjin-ro, Daebang-dong, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplements, household and animal care, and contract manufacturing of active pharmaceutical ingredients. The company offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.